ERX:ARCA-Direxion Energy Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 13.31

Change

-1.23 (-8.46)%

Market Cap

USD 0.44B

Volume

3.37M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the Energy Select Sector Index. The fund creates long positions by investing at least 80% of its assets in the securities that comprise the Energy Select Sector Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is provided by S&P Dow Jones Indices (the "index provider") and includes domestic companies from the energy sector which includes the following industries: oil, gas and consumable fuels; and energy equipment and services. The fund is non-diversified.

Inception Date: 06/11/2008

Primary Benchmark: S&P Energy Select Sector TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.96%

Management Expense Ratio: 1.08 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
SCPS Scopus Biopharma Inc 5.84 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-01-27 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

-4.12 (-11.80%)

USD 10.94B
QLD ProShares Ultra QQQ 0.95 %

-3.25 (-4.11%)

USD 5.97B
SSO ProShares Ultra S&P500 0.90 %

-1.22 (-1.73%)

USD 4.66B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

-32.05 (-11.05%)

USD 4.21B
SPXL Direxion Daily S&P500® Bull 3.. 1.00 %

-2.98 (-2.58%)

USD 4.15B
TECL Direxion Daily Technology Bull.. 1.17 %

-4.21 (-6.33%)

USD 3.23B
UPRO ProShares UltraPro S&P500 0.92 %

-1.62 (-2.67%)

USD 2.95B
FAS Direxion Daily Financial Bull .. 1.04 %

+3.79 (+4.03%)

USD 2.45B
TNA Direxion Daily Small Cap Bull .. 1.10 %

+0.12 (+0.37%)

USD 2.23B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

-1.99 (-2.26%)

USD 1.24B

ETFs Containing ERX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.94% 5% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.94% 5% F 2% F
Trailing 12 Months  
Capital Gain -32.61% 3% F 9% A-
Dividend Return 1.38% 76% C+ 26% F
Total Return -31.23% 3% F 9% A-
Trailing 5 Years  
Capital Gain -76.30% 7% C- 5% F
Dividend Return 1.85% 39% F 8% B-
Total Return -74.45% 7% C- 4% F
Average Annual (5 Year Horizon)  
Capital Gain -9.37% 5% F 11% F
Dividend Return -8.61% 5% F 9% A-
Total Return 0.76% 65% D 18% F
Risk Return Profile  
Volatility (Standard Deviation) 41.86% 41% F 10% F
Risk Adjusted Return -20.57% 3% F 15% F
Market Capitalization 0.44B 73% C 36% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.